Risk factor clustering in patients with hypertension and non-insulin- dependent diabetes mellitus. The Skaraborg Hypertension Project

Journal of Internal Medicine

Volumn 243, Issue 3, 1998, Pages 223-232

  Bog Hansen E ^a,b   Lindblad, U ^b,c   Bengtsson, K ^a,b   Ranstam, J ^d   Melander, A ^d   Rastam L ^b,e  

^a Skara Health Care Centre   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Skaraborgs Institutet   (Sweden)

^d Network for Pharmacoepidemiology Foundation   (Sweden)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Clustering; Hypertension; NIDDM; Primary health care; Risk factors; Treatment goals

Indexed keywords

ADULT; AGED; ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATION; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

EID: 0031864427     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00286.x     Document Type: Article

References (36)

1. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc 1991; 265: 3255-64.
2. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-35.
3. Whisnant JP. The decline of stroke. Stroke 1984; 15: 160-8.
4. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? J Am Med Assoc 1991; 265; 489-95.
5. Lindblad U, Rastam L, Rydén L, Ranstam J, Isacsson S-O, Berglund G. Control of blood pressure and risk of first acute myocardial infarction: Skaraborg Hypertension Project. Br Med J 1994; 308: 681-6.
6. Andersson DKG, Svärdsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1996; 18: 1534-43.
7. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl J Med 1993; 329: 977-86.
8. Swales JD. Management guidelines for hypertension: is anyone taking notice? J Hum Hypertens 1995; 9: 9-13.
9. Editorial. Type 2 diabetes or NIDDM: looking for a better name. Lancet 1989; i: 589-91.
10. Criqui MH, Barrett-Connor E, Holdbrook MJ, Austin M, Turner JD. Clustering of cardiovascular disease risk factors. Prev Med 1980; 9: 525-33.
11. Bonaa K, Thelle D. Association between blood pressure and serum lipids in a population. The Tromso Study. Circulation 1991; 83: 1305-14.
12. The Hypertension in Diabetes Study Group. Hypertension in diabetes study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factor for cardiovascular and diabetic complications. J Hypertens 1993; 11: 309-17.
13. Kannel WB. Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol 1987; 59: 80A-90A.
14. Samuelsson O, Wilhelmsen L, Andersson OK, Pennert K, Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the Primary Prevention Trial in Göteborg, Sweden. J Am Med Assoc 1987; 258: 1768-76.
15. The Hypertension in Diabetes Study droup. Hypertension in diabetes study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens 1993; 11: 319-25.
16. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
17. Haffner SM. The insulin resistance syndrome revisited. Diabetes Care 1996; 19: 275-7.
18. Berglund G, Isacsson S-O, Rydén L. The Skaraborg Project-a controlled trial regarding the effect of structured hypertension care. Acta Med Scand 1979; 205 (suppl 626); 64-8.
19. Råstam L, Berglund G, Isacsson S-O, Rydén L. The Skaraborg Hypertension Project. II. Feasibility of a medical care program for hypertension. Acta Med Scand 1986; 219: 249-60.
20. Rastam L, Berglunc G, Isacsson S-O, Rydém L. The Skaraborg Hypertension Project. III. Influence on blood pressure of a medical care program for hypertension. Acta Med Scand 1986; 219: 261-9.
21. Eckerlund I, Jonsson E, Rydén L, Rastam L, Berglund G, Isacsson S-O. Economic evaluation of a Swedish medical care program for hypertension. Health Policy 1985; 5: 299-306.
22. Lindblad U, Råstam L, Rydén L, Ranstam J, Berglund G, Isacsson S-O. Reduced stroke incidence with structured hypertension care: The Skaraborg Hypertension Project. J Hypertens 1990; 8: 1147-53.
23. Lindblad U, Rastam L, Ranstam J. Stroke morbidity in patients treated for hypertension: The Skaraborg Hypertension Project. J Intern Med 1993; 233: 155-163.
24. Lindblad U, Råstam L, Ranstam J. Acute myocardial infarction in patients treated for hypertension in The Skaraborg Hypertension Project. Eur Heart J 1993; 14: 291-6.
25. Treatment of mild hypertension. Stockholm: National Board of Health and Welfare, Drug Information Committee, Sweden, 1987; 1.
26. Behandling av hypertoni hos äldre. Stockholm: Information fran Läkemedelsverket, 1993: 1 (in Swedish).
27. World Health Organization Expert Committee. Diabetes mellitus. Technical Report series no. 742. Geneva, Switzerland 1985.
28. Treatment of non-insulin-dependent diabetes mellitus. Stockholm: Medical Products Agency. Sweden 1990; 1.
29. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods, 2nd edn. Geneva: World Health Organization 1982; 123-9.
30. Rastam L, Sjönell G. A new device for measuring blood pressure in adults (Letter). Lancet 1991; 337: 249-50.
31. Nilsson P, Andersson DKG, Andersson P-E, Schwan A, Üstlind B, Malmborg R, Lithell H. Cardiovascular risk factors in treated hypertensives-a nationwide, cross-sectional study in Sweden. J Intern Med 1993; 233: 239-45.
32. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl Med 1989; 321: 868-73.
33. Samuelsson O, Hedner T, Berglund G, Persson B, Andersson OK, Wilhelmsen L. Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiaxide diuretics during 15 years' treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. J Hum Hypertens 1994; 8: 257-63.
34. Hosie J, Wiklund I. Managing hypertension in general practice: can we do better? J Hum Hypertens 1995; 9: 15-8.
35. Puska P, Tuomilehto J, Salonen JT, Neittaamaki L, Maki J, Virtamo J, et al. Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J 1979; 2: 1173-8.
36. O'Connor PJ, Wagner EH, Strogatz DS. Hypertension control in a rural community. An assessment of community-oriented primary care. J Fam Prac 1990; 30: 420-4.